Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/hg84-js27

technical paper

ENDO 2020

June 10, 2020

Virtual, United States

A Phase 3 Study of a Modified-Release Hydrocortisone in the Treatment of Congenital Adrenal Hyperplasia

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2020

Nuclear Receptor CAR Protects Female Mice from the Development of Diet-Induced Nonalcoholic Fatty Liver Disease
technical paper

Nuclear Receptor CAR Protects Female Mice from the Development of Diet-Induced Nonalcoholic Fatty Liver Disease

ENDO 2020

+1Laila LAKHALFabiana Layla Oliviero
Fabiana Layla Oliviero and 3 other authors

10 June 2020

Similar lecture

Developing Novel Combination Therapies for Medullary Thyroid Cancer
technical paper

Developing Novel Combination Therapies for Medullary Thyroid Cancer

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved